| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6144566 | American Journal of Obstetrics and Gynecology | 2015 | 10 Pages |
Abstract
Our cost-benefit analysis provides the economic evidence for the adoption of PAMG-1 in diagnosing preterm premature rupture of membranes in uncertain presentations and when CTDT is equivocal at 34 to <37 weeks' gestation.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Nelson C. MD, MBA, M. Maya PhD, MPH, Jessica A. MD, Meaghan M. MD, Natasha N. MD, Nora M. MD, MPH,